BC179 Relieves Discomfort After Drinking

Weizmannia Coagulans BC179 Alleviates Post-Alcohol Discomfort May Via Taurine-Related Metabolism and Antioxidant Regulation: A Randomized, Double-Blind，Placebo-Controlled Trial

To assess the effectiveness and safety of probiotic strain BC179 in reducing alcohol absorption in the gut, thereby lowering health risks.

• Inclusion Criteria:

  1. Participants must be aged between 18 and 65 years.
  2. They should have a documented history of long-term alcohol consumption, defined as consuming at least 20 grams of ethanol per day for at least one year. This is calculated using the formula: volume (mL) × alcohol content (%) × 0.8.
  3. They must provide written informed consent and be willing to comply with the study procedures.

• Exclusion Criteria:

  1. History of chronic liver, gastrointestinal, or systemic metabolic disorders.
  2. Use of products with similar functions to the investigational formulation within the past two weeks.
  3. Use of antibiotics, laxatives, or dietary supplements within the past four weeks.
  4. Documented history of hypertension or diabetes.
  5. Severe allergies or immune deficiencies.
  6. Pregnancy, lactation, or planning pregnancy without effective contraception during the study period.